Cargando…

Bictegravir and Metformin Drug-Drug Interaction in People with Human Immunodeficiency Virus (HIV)

A drug-drug interaction (DDI) exists between bictegravir and metformin. Bictegravir inhibits renal organic cation transporter-2, leading to increased metformin plasma concentrations. The objective of this analysis was to evaluate the clinical implications of concomitant bictegravir and metformin adm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masich, Anne M., Thompson, Lindsey, Fulco, Patricia P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204476/ https://www.ncbi.nlm.nih.gov/pubmed/37218815 http://dx.doi.org/10.3390/idr15030024

Ejemplares similares

Bictegravir-Induced Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Acute Human Immunodeficiency Virus
por: DiLorenzo, Madeline A, et al.
Publicado: (2023)

Case Report: Emergent Resistance in a Treatment-Naive Person With Human Immunodeficiency Virus Under Bictegravir-Based Therapy
por: Chamberlain, Nicholas, et al.
Publicado: (2021)

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
por: Sax, Paul E, et al.
Publicado: (2020)

Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
por: Sellem, Baptiste, et al.
Publicado: (2023)

Physiologically‐Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir
por: Stader, Felix, et al.
Publicado: (2021)

Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
por: Smith, Steven J., et al.
Publicado: (2018)

Pharmacokinetics of Bictegravir in Older Japanese People Living with HIV-1
por: Kawashima, Akira, et al.
Publicado: (2023)

Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications
por: Kaur, Kirpal, et al.
Publicado: (2015)

Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus
por: Nolan, Nathanial S, et al.
Publicado: (2021)

Heart transplantation and human immunodeficiency virus–navigating drug-drug interactions: a case report
por: Almangour, Thamer A., et al.
Publicado: (2023)

HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir
por: Rock, Alex E., et al.
Publicado: (2020)

Patterns of human immunodeficiency virus drug resistance mutations in people living with human immunodeficiency virus in India: A scoping review
por: Balaji, Sivaraman, et al.
Publicado: (2022)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023)

1047. Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV
por: Vo, Daniel, et al.
Publicado: (2020)

Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
por: Rolle, Charlotte-Paige, et al.
Publicado: (2021)

Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
por: Chen, I-Wen, et al.
Publicado: (2021)

Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Metformin for Preventing Progression From Prediabetes to Diabetes Mellitus in People Living With Human Immunodeficiency Virus
por: Nimitphong, Hataikarn, et al.
Publicado: (2022)

Lack of Clinically Relevant Effect of Bictegravir (BIC, B) on Metformin (MET) Pharmacokinetics (PK) and Pharmacodynamics (PD)
por: Custodio, Joseph, et al.
Publicado: (2017)

From Hospital to the Community: Redesigning the Human Immunodeficiency Virus (HIV) Clinical Service Model to Respond to an Outbreak of HIV Among People Who Inject Drugs
por: Metcalfe, Rebecca, et al.
Publicado: (2020)

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
por: Woldemeskel, Bezawit A, et al.
Publicado: (2021)

Prevalence and patterns of illicit drug use in people with human immunodeficiency virus infection in Korea
por: Lee, Soon Ok, et al.
Publicado: (2021)

Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review
por: Amariles, Pedro, et al.
Publicado: (2023)

Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African Countries
por: Dear, Nicole, et al.
Publicado: (2021)

Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients
por: Schafer, Jason J, et al.
Publicado: (2020)

HIV Test Avoidance Among People Who Inject Drugs in Thailand
por: Ti, Lianping, et al.
Publicado: (2012)

Impact of Co-occurring Drug Use, Hazardous Alcohol Use, and Mental Health Disorders on Drug Use Patterns in People With HIV and Hepatitis C Virus Infection
por: McCormick, Sean, et al.
Publicado: (2021)

Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
por: Deeks, Emma D.
Publicado: (2018)

Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes
por: White, Kirsten L., et al.
Publicado: (2021)

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
por: Sax, Paul E., et al.
Publicado: (2018)

Human Immunodeficiency Virus-1 and Preconception Care
por: Lampe, Margaret A.
Publicado: (2006)

Symptoms of Autonomic Dysfunction in Human Immunodeficiency Virus
por: Chow, Dominic, et al.
Publicado: (2015)

Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).
por: D'Aquila, R. T., et al.
Publicado: (1987)

1611. Real-World Effectiveness and Tolerability of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People With HIV and a History of Antiretroviral Drug Resistance Mutations
por: Trottier, Benoit, et al.
Publicado: (2023)

Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in Pakistan
por: Lim, Aaron G, et al.
Publicado: (2021)

Drug Interactions of Metformin Involving Drug Transporter Proteins
por: Pakkir Maideen, Naina Mohamed, et al.
Publicado: (2017)

An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1
por: Liu, An, et al.
Publicado: (2022)

Myocardial Inflammatory Changes Before and After Antiretroviral Therapy Initiation in People With Advanced Human Immunodeficiency Virus Disease
por: Piñeirua-Menéndez, A, et al.
Publicado: (2020)

Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance Programs
por: McManus, Kathleen A, et al.
Publicado: (2022)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cmnbsjanj5ahogod36qrg3g928